Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LUNG NASDAQ:NTRB NASDAQ:TELA OTCMKTS:UEEC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLUNGPulmonx$1.70+0.6%$2.14$1.47▼$9.37$68.86M0.43562,197 shs248,472 shsNTRBNutriband$7.15+3.2%$7.15$3.72▼$11.78$83.40M1.1332,104 shs18,318 shsTELATELA Bio$1.58-2.5%$1.80$0.86▼$3.26$64.18M0.8482,680 shs39,397 shsUEECUnited Health Products$0.07+2.0%$0.09$0.05▼$0.28$18.86M-1.48231,358 shs25,847 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLUNGPulmonx+0.59%-2.30%+10.39%-43.89%-78.06%NTRBNutriband+3.17%+12.07%+7.36%0.00%+86.20%TELATELA Bio-2.47%-0.63%+7.85%-7.06%-40.15%UEECUnited Health Products+2.04%+6.54%-12.19%-41.25%-53.22%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLUNGPulmonx$1.70+0.6%$2.14$1.47▼$9.37$68.86M0.43562,197 shs248,472 shsNTRBNutriband$7.15+3.2%$7.15$3.72▼$11.78$83.40M1.1332,104 shs18,318 shsTELATELA Bio$1.58-2.5%$1.80$0.86▼$3.26$64.18M0.8482,680 shs39,397 shsUEECUnited Health Products$0.07+2.0%$0.09$0.05▼$0.28$18.86M-1.48231,358 shs25,847 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLUNGPulmonx+0.59%-2.30%+10.39%-43.89%-78.06%NTRBNutriband+3.17%+12.07%+7.36%0.00%+86.20%TELATELA Bio-2.47%-0.63%+7.85%-7.06%-40.15%UEECUnited Health Products+2.04%+6.54%-12.19%-41.25%-53.22%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLUNGPulmonx 2.56Moderate Buy$7.66350.84% UpsideNTRBNutriband 3.00Buy$13.0081.82% UpsideTELATELA Bio 2.50Moderate Buy$4.50184.81% UpsideUEECUnited Health Products 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest UEEC, NTRB, LUNG, and TELA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/8/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$16.008/1/2025LUNGPulmonxWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$6.00 ➝ $3.007/31/2025LUNGPulmonxLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.00 ➝ $8.007/31/2025LUNGPulmonxStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$16.00 ➝ $5.007/31/2025LUNGPulmonxD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$17.00 ➝ $16.007/31/2025LUNGPulmonxPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOverweight ➝ Neutral$9.00 ➝ $2.50(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLUNGPulmonx$83.79M0.83N/AN/A$2.17 per share0.78NTRBNutriband$2.14M40.19N/AN/A$0.71 per share10.07TELATELA Bio$69.30M0.90N/AN/A$0.72 per share2.19UEECUnited Health Products$40K481.16N/AN/A($0.01) per share-7.49Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLUNGPulmonx-$56.39M-$1.43N/AN/AN/A-62.88%-69.76%-36.26%10/29/2025 (Estimated)NTRBNutriband-$10.48M-$2.87N/AN/AN/A-398.29%-85.40%-73.45%12/2/2025 (Estimated)TELATELA Bio-$37.84M-$1.12N/AN/AN/A-54.12%-329.48%-57.34%11/6/2025 (Estimated)UEECUnited Health Products-$2M-$0.02N/A∞N/AN/AN/A-1,954.81%N/ALatest UEEC, NTRB, LUNG, and TELA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/9/2025Q2 2026NTRBNutriband-$0.17-$2.12-$1.95-$2.12$0.71 million$0.62 million8/11/2025Q2 2025TELATELA Bio-$0.18-$0.22-$0.04-$0.22$20.67 million$20.20 million7/30/2025Q2 2025LUNGPulmonx-$0.40-$0.38+$0.02-$0.38$23.46 million$23.86 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLUNGPulmonxN/AN/AN/AN/AN/ANTRBNutribandN/AN/AN/AN/AN/ATELATELA BioN/AN/AN/AN/AN/AUEECUnited Health ProductsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLUNGPulmonx0.545.354.63NTRBNutriband0.014.783.48TELATELA Bio4.143.192.59UEECUnited Health ProductsN/A0.010.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLUNGPulmonx91.04%NTRBNutriband19.70%TELATELA Bio94.35%UEECUnited Health Products0.07%Insider OwnershipCompanyInsider OwnershipLUNGPulmonx6.80%NTRBNutriband54.09%TELATELA Bio4.70%UEECUnited Health Products1.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLUNGPulmonx25040.75 million37.98 millionOptionableNTRBNutriband1012.03 million5.53 millionNot OptionableTELATELA Bio12039.62 million37.75 millionOptionableUEECUnited Health Products4256.96 million253.10 millionNot OptionableUEEC, NTRB, LUNG, and TELA HeadlinesRecent News About These CompaniesUnited Health Products (OTCMKTS:UEEC) versus Valneva (NASDAQ:VALN) Critical ComparisonSeptember 4, 2025 | americanbankingnews.comUnited Health Products Provides Regulatory Application UpdateJune 6, 2025 | finance.yahoo.comUnited Health Products Announces OTCQB Uplisting and FDA UpdateMay 1, 2025 | finance.yahoo.comUnited Health Products Provides Update on FDA and OTC Markets ApplicationsMarch 28, 2025 | finance.yahoo.comUnited Health Products Provides Update on Capital Markets and Regulatory ProcessesMarch 14, 2025 | finance.yahoo.comUnited Health Products Provides Update on Clinical Study ProcessDecember 2, 2024 | globenewswire.com2 recalls impacting Lubbock area supermarkets, including H-E-B, Walmart, UnitedOctober 31, 2024 | yahoo.comUnited Laboratories’ Antibiotic Product Gains Key ApprovalOctober 26, 2024 | msn.comEco Bandage, Greener Living Products receive ECRM Health Care Buyers’ Choice AwardsOctober 14, 2024 | drugstorenews.comDUnited overhauls economy-class wine menu with 4 new optionsOctober 1, 2024 | thepointsguy.comTUnited Supermarkets Partners on New Health Care BenefitSeptember 30, 2024 | progressivegrocer.comPRising Extreme Heat Compounds the U.S. Maternal Health CrisisSeptember 30, 2024 | americanprogress.orgAUnited Healthcare cuts UF Health from in-provider networkSeptember 5, 2024 | mainstreetdailynews.comMUnited Therapeutics: Strong Buy Rating on FDA Exclusivity and Market Dominance for Tyvaso DPIAugust 20, 2024 | markets.businessinsider.comUnited Health Products Submits Response Letter to FDAAugust 19, 2024 | globenewswire.comFDA warns producer about lead levels in its apple cinnamon puree productsAugust 17, 2024 | msn.comUnitedHealthcare: Health care coverage and benefitsAugust 14, 2024 | unitedhealthgroup.comUHealth Headlines: How to spot ultra-processed foodsAugust 13, 2024 | msn.comUnited Health Products Inc.May 25, 2024 | wsj.comStudy finds front-of-package nutrition labeling results in healthier productsMay 15, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is ExpectedBy Thomas Hughes | September 4, 2025UEEC, NTRB, LUNG, and TELA Company DescriptionsPulmonx NASDAQ:LUNG$1.70 +0.01 (+0.59%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.67 -0.03 (-1.76%) As of 09/12/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.Nutriband NASDAQ:NTRB$7.15 +0.22 (+3.17%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$7.02 -0.14 (-1.89%) As of 09/12/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.TELA Bio NASDAQ:TELA$1.58 -0.04 (-2.47%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.58 +0.00 (+0.32%) As of 09/12/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.United Health Products OTCMKTS:UEEC$0.07 +0.00 (+2.04%) As of 09/12/2025 03:57 PM EasternUnited Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
